FDA Approves Biogen's MS Drug Plegridy

Home › FDA Approves Biogen's MS Drug Plegridy

Biogen Idec says that federal regulators have approved the specialty drugmaker's new treatment for people with relapsing forms of multiple sclerosis.

08.11	Hurricane Rafael Graphics
08.11	Hurricane Rafael Wind Speed Probabilities Number 22
08.11	Hurricane Rafael Forecast Advisory Number 22
08.11	Hurricane Rafael Public Advisory Number 22
08.11	Summary for Hurricane Rafael (AT3/AL182024)
08.11	Trump tariffs could cost UK 22bn of exports
08.11	Watchdog to review police handling of Al Fayed abuse claims
08.11	Cattle marketing: Its about making the right decisions
More »

je.st